Konstantin Kazarian

Konstantin Kazarian, PhD, is an experienced executive in business development within the biotechnology and pharmaceutical sectors. Currently serving as Vice President of Business Development (US West) at Northway Biotech since September 2025, Konstantin also co-founded Hybrid Biotherapeutics Inc. in August 2023. Previously, Konstantin held the position of Senior Director of Business Development at Oxford Biomedica from September 2023 to September 2025 and served as Senior Director of Business Development for North America at Rentschler Biopharma SE from July 2020 to August 2023. Earlier roles include Associate Director of Business Development/Project Management and Project Manager at PYRAMID Laboratories Inc., as well as Project Scientist at UC Irvine. Additional experience includes leadership positions in various organizations, including Director/Division Head at the Open Innovations Forum and Business Development Director at VR Foundation. Konstantin's educational background includes a PhD in Biochemistry from the Bakh Institute of Biochemistry and post-doctoral studies in Structural Biology and Biochemistry at Thomas Jefferson University.